Regional control after precision lymph node dissection for clinically evident melanoma metastasis
- 17 September 2022
- journal article
- research article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 127 (1) , 140-147
Abstract
Introduction: Completion lymph node dissection (CLND) for microscopic lymph node metastases has been replaced by observation; however, CLND is standard for clinically detectable nodal metastases (cLN). CLND has high morbidity, which may be reduced by excision of only the cLN (precision lymph node dissection [PLND]). We hypothesized that same‐basin recurrence risk would be low after PLND.Methods: Retrospective review at four tertiary care hospitals identified patients who underwent PLND. The primary outcome was 3‐year cumulative incidence of isolated same‐basin recurrence.Results: Twenty‐one patients underwent PLND for cLN without synchronous distant metastases. Reasons for forgoing CLND included patient preference (n = 11), comorbidities (n = 5), imaging indeterminate for distant metastases (n = 2), partial response to checkpoint blockade (n = 1), or not reported (n = 2). A median of 2 nodes (range: 1–6) were resected at PLND, and 68% contained melanoma. Recurrence was observed in 33% overall. Only 1 patient (5%) developed an isolated same‐basin recurrence. Cumulative incidences at 3 years were 5.0%, 17.3%, and 49.7% for isolated same‐basin recurrence, any same‐basin recurrence, and any recurrence, respectively. Complications from PLND were reported in 1 patient (5%).Conclusions: These pilot data suggest that PLND may provide adequate regional disease control with less morbidity than CLND. These data justify prospective evaluation of PLND in select patients.Keywords
Funding Information
- University of Virginia (Farrow Fellowship, Rebecca Clary Harris Memorial Fellowship)
This publication has 30 references indexed in Scilit:
- Completion Dissection or Observation for Sentinel-Node Metastasis in MelanomaNew England Journal of Medicine, 2017
- Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trialThe Lancet Oncology, 2016
- Complications following inguinal and ilioinguinal lymphadenectomies: a meta-analysisJournal of Plastic Surgery and Hand Surgery, 2016
- Risk factors associated with lymphedema after lymph node dissection in melanoma patientsThe American Journal of Surgery, 2015
- Therapeutic Lymph Node Dissection in Melanoma: Different Prognosis for Different Macrometastasis Sites?Annals of Surgical Oncology, 2012
- Systematic review and meta-analysis of the used surgical techniques to reduce leg lymphedema following radical inguinal nodes dissectionSurgical Oncology, 2011
- Prospective Assessment of Postoperative Complications and Associated Costs Following Inguinal Lymph Node Dissection (ILND) in Melanoma PatientsAnnals of Surgical Oncology, 2010
- Inguinal node dissection for melanoma in the era of sentinel lymph node biopsySurgery, 2007
- Lymphedema After Complete Axillary Node Dissection for MelanomaAnnals of Surgery, 2004
- Groin dissection in malignant melanomaBritish Journal of Surgery, 1994